PLAGL1 anticorps (AA 1-100) (Biotin)

N° du produit ABIN1389901

Cet anticorps Lapin Polyclonal détecte spécifiquement PLAGL1 dans ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Souris.

Aperçu rapide pour PLAGL1 anticorps (AA 1-100) (Biotin) (ABIN1389901)

Antigène: PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLAGL1 est conjugé à/à la Biotin

Application: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-PLAGL1 anticorps (Biotin)

Épitope: AA 1-100

Réactivité croisée: Souris

Homologie: Human,Rat,Dog,Pig,Zebrafish

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human PLAGL1

Isotype: IgG

Information d'application

Indications d'application: IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur PLAGL1

Antigène: PLAGL1 (Pleiomorphic Adenoma Gene-Like 1 (PLAGL1))

Autre désignation: PLAGL1/ZAC1

Sujet:

Synonyms: DKFZp781P1017, Lost on transformation 1, Lost on Transformation, LOT-1, LOT1, MGC126275, MGC126276, PLAG like 1, PLAGL1, PLAL1_HUMAN, Pleiomorphic adenoma gene like 1, Pleiomorphic adenoma gene like protein 1, Pleiomorphic adenoma-like protein 1, Tumor supressor ZAC, ZAC, ZAC tumor supressor, ZAC1, Zinc finger protein PLAGL1.

Background: This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activities. It has been shown to have anti-proliferative properties, and thus thought to function as a tumor suppressor. In addition, overexpression of this gene during fetal development is believed to underlie the rare disorder, transient neonatal diabetes mellitus (TNDM). This gene is imprinted, with preferential expression of the paternal allele in many tissues, however, biallelic expression has been noted in peripheral blood leucocytes. A recent study reports that tissue-specific imprinting results from variable utilization of monoallelic and biallelic promoters. Many transcript variants differing in the 5' UTR and encoding two different isoforms, have been found for this gene. [provided by RefSeq, Oct 2010].